Generation of gene corrected human isogenic iPSC lines (IDVi003-A_CR13, IDVi003-A_CR21, IDVi003-A_CR24) from an inherited retinal dystrophy patient-derived IPSC line ITM2B-5286-3 (IDVi003-A) carrying the ITM2B c.782A > C variant using CRISPR/Cas9
- PMID: 37473460
- DOI: 10.1016/j.scr.2023.103166
Generation of gene corrected human isogenic iPSC lines (IDVi003-A_CR13, IDVi003-A_CR21, IDVi003-A_CR24) from an inherited retinal dystrophy patient-derived IPSC line ITM2B-5286-3 (IDVi003-A) carrying the ITM2B c.782A > C variant using CRISPR/Cas9
Abstract
The ITM2B-related retinal dystrophy (ITM2B-RD) was identified within patients carrying the autosomal dominant variant [c.782A > C, p.(Glu261Ala)] in ITM2B from whom induced pluripotent stem cell (IPSC) lines were previously generated. Here, we report the generation of three isogenic control iPSC lines from the derived affected subject cell line (ITM2B-5286-3) using CRISPR/Cas9 engineering. The three generated lines express pluripotency markers, can be differentiated into the three germ layers and present a normal karyotype. The generated iPSC lines can be used to study the implications of ITM2B-RD variant in vitro.
Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. This research was funded by , LABEX LIFESENSES (reference ANR-10-LABX-65 ), IHU FOReSIGHT (ANR-18-IAHU-0001) supported by French state funds managed by the Agence Nationale de la Recherche within the 24 Investissements d’Avenir program, Retina France and Foundation Fighting Blindness center grant (C-CMM-0907-0428-INSERM04)
Similar articles
-
Generation of human induced pluripotent stem cell lines from a patient with ITM2B-related retinal dystrophy and a non mutated brother.Stem Cell Res. 2019 Dec;41:101625. doi: 10.1016/j.scr.2019.101625. Epub 2019 Nov 5. Stem Cell Res. 2019. PMID: 31731182
-
Generation of human induced pluripotent stem cell lines from a subject with UBAP1L-associated retinal dystrophy and CRISPR/cas9-corrected isogenic iPSC lines.Stem Cell Res. 2024 Dec;81:103558. doi: 10.1016/j.scr.2024.103558. Epub 2024 Sep 11. Stem Cell Res. 2024. PMID: 39293306
-
The familial dementia gene revisited: a missense mutation revealed by whole-exome sequencing identifies ITM2B as a candidate gene underlying a novel autosomal dominant retinal dystrophy in a large family.Hum Mol Genet. 2014 Jan 15;23(2):491-501. doi: 10.1093/hmg/ddt439. Epub 2013 Sep 10. Hum Mol Genet. 2014. PMID: 24026677
-
Generation of two induced pluripotent stem cell lines (TMOi001-A-5, TMOi001-A-6) carrying variants in DISC1 exon 2 using CRISPR/Cas9 gene editing.Stem Cell Res. 2022 Oct;64:102925. doi: 10.1016/j.scr.2022.102925. Epub 2022 Sep 20. Stem Cell Res. 2022. PMID: 36154917
-
Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9.Stem Cell Rev Rep. 2018 Jun;14(3):323-336. doi: 10.1007/s12015-018-9811-3. Stem Cell Rev Rep. 2018. PMID: 29623532 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous